Zuogui Jiangtang Shuluo Formula
Preclinical
Zuogui Jiangtang Shuluo Formula is one of 5 therapeutic programs targeting Diabetic Peripheral Neuropathy. It is currently in Preclinical.
1
Indications
1
Total Trials
1
Active Trials
4
Competitors
Pipeline
Status by Indication[2][1]
Indication
Competition
Competitive Landscape
4 competitors in Diabetic Peripheral Neuropathy
#DrugCompanyPhaseTrials
1Benfotiamine
RRuhr University of Bochum
Phase 3
Cymbalta
Jazz PharmaceuticalsPreclinical
Mecobalamin
EisaiPreclinical
Alpha Lipoic Acid
NNational Center for Complementary and Integrative Health (NCCIH)
Preclinical
Zuogui Jiangtang Shuluo Formula
TThe First Affiliated Hospital of Hunan University of Traditional Chinese Medicine
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Diabetic Peripheral Neuropathy1 trial
Mechanistic Study of Zuogui Jiangtang Shuluo Formula in Regulating Lipid Metabolism and Inhibiting Ferroptosis for the Prevention and Treatment of Diabetic Peripheral Neuropathy
Not yet recruiting·TThe First Affiliated Hospital of Hunan University of Traditional Chinese Medicine·Preclinical·NCT07771894·74 enrolled
Sources
References
- [1]
- [2]
- [3]
Details
Drug Info
Quick Facts
- Highest Phase
- Preclinical[1]